Dan Mulreany leads our Business Development & Strategy team. Prior to joining Apogee, Mr. Mulreany served as Vice President of Business Development and Operations at BridgeBio where his responsibilities included leading business development for the company’s clinical-stage oncology programs. Previously, he consulted for Bain & Company in San Francisco and supported the development of monoclonal antibodies to treat cancer and I&I diseases as a member of the immunology pre-clinical research group at Human Genome Sciences. He has served as a board member of the Wharton Healthcare Management Alumni Association. Mr. Mulreany received his B.S. from Johns Hopkins University and holds an M.S.E. in Biomedical Engineering from Johns Hopkins as well as an M.B.A with majors in Finance and Healthcare Management from The Wharton School of the University of Pennsylvania. He is a tennis player and fan who has slept on the sidewalk while queuing for tickets to Wimbledon.